bluesmiley
Established Member
- Reaction score
- 0
I expressed similar sentiments about the FDA in another thread related to alternatives to propecia (like Eucapil), but What_a_Pity does a much better job in this thread.
http://www.hairlosshelp.com/forums/mess ... TARTPAGE=3
You'll have to scroll down a bit to read his words, but here's a telling snippet:
http://www.hairlosshelp.com/forums/mess ... TARTPAGE=3
You'll have to scroll down a bit to read his words, but here's a telling snippet:
Old Baldy, despite the wisdom embodied by the "will of Congress" there are still a lot of snake oil products out there. Avacor, folliguard,****, viviscal, etc. etc. Go to any drug store and you will see all sorts of "cures" for hair loss, such as "nu hair."
But Congress and the FDA have succeeded in making it VERY expensive to bring a new drug to market. The figure is $900 million. So a drug company--which has a responsibility of maximizing profits for its shareholders--has to believe not only that the drug will be economically viable, but that it would yield such a profit that it would cover this huge initial investment.
Drugs that are efficacious but not profitable simply won't be developed. Indeed, as has been noted on this forum several times, Propecia hasn't been profitable for Merck. So future (more effective) versions of propecia simply won't come to market.
People have asked why RU-58841 hasn't made it to market in the US. Others wonder why fluridil hasn't made it to market in the US. Could it be possible that the high regulatory walls are diminishing consumer choice and retarding the discovery of treatments?
